Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Liver Diseases

  Free Subscription

Articles published in Radiology

Retrieve available abstracts of 182 articles:
HTML format

Single Articles

    May 2024
  1. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    PubMed     Abstract available

  2. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    PubMed     Abstract available

  3. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    PubMed     Abstract available

  4. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.

    April 2024
  5. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    PubMed     Abstract available

  6. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    PubMed     Abstract available

  7. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.

  8. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.

  9. ZENG QQ, Liang P
    Super-Resolution US Imaging of Focal Nodular Hyperplasia.
    Radiology. 2024;311:e233130.

  10. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
    US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
    Radiology. 2024;311:e231461.
    PubMed     Abstract available

    March 2024
  11. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    PubMed     Abstract available

  12. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    PubMed     Abstract available

    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.

    February 2024
    Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
    Radiology. 2024;310:e240072.

  15. AUER TA, Muller L, Schulze D, Anhamm M, et al
    CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
    Radiology. 2024;310:e232044.
    PubMed     Abstract available

  16. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    PubMed     Abstract available

    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.

    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.

  19. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    PubMed     Abstract available

  20. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    PubMed     Abstract available

  21. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.

    January 2024
  22. MA L, Zhang W, Ma J, Luo J, et al
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
    Radiology. 2024;310:e232499.

  23. TAN XZ, Chen X, Liu P
    Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
    Radiology. 2024;310:e232349.

  24. KADI D, Loomba R, Bashir MR
    Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
    Radiology. 2024;310:e222695.
    PubMed     Abstract available

  25. FOWLER KJ, Chernyak V
    What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
    Radiology. 2024;310:e232771.

    Modified Algorithm for Contrast-enhanced US LI-RADS.
    Radiology. 2024;310:e232742.

    December 2023
  27. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
    Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
    Radiology. 2023;309:e231656.
    PubMed     Abstract available

  28. SIRLIN CB, Chernyak V
    Are We Ready to Simplify and Improve LI-RADS?
    Radiology. 2023;309:e233164.

  29. TAMIR S, Tau N
    Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
    Radiology. 2023;309:e233123.

  30. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
    Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222776.
    PubMed     Abstract available

    November 2023
  31. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    PubMed     Abstract available

  32. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    PubMed     Abstract available

  33. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.

  34. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    PubMed     Abstract available

  35. TAN XZ, Liu P, Xiang H
    The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
    Radiology. 2023;309:e231141.

    October 2023
    Advancing AI-assisted US Screening for Fatty Liver.
    Radiology. 2023;309:e232442.

  37. HAN A
    Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
    Radiology. 2023;309:e232475.

  38. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
    Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
    Radiology. 2023;309:e230659.
    PubMed     Abstract available

  39. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
    Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
    Radiology. 2023;309:e230341.
    PubMed     Abstract available

  40. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
    Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
    Radiology. 2023;309:e230727.
    PubMed     Abstract available

  41. HEO S, Lee SS, Choi SH, Kim DW, et al
    CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
    Radiology. 2023;309:e231208.
    PubMed     Abstract available

  42. FRAUM TJ
    CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
    Radiology. 2023;309:e232439.

  43. XIA T, Du M, Li H, Wang Y, et al
    Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Radiology. 2023;309:e231007.
    PubMed     Abstract available

  44. REEDER SB, Starekova J
    MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
    Radiology. 2023;309:e232552.

    Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
    Radiology. 2023;309:e232551.

  46. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
    Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
    Radiology. 2023;309:e231092.
    PubMed     Abstract available

  47. KOZAKA K, Matsui O
    MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
    Radiology. 2023;309:e232420.

    September 2023
  48. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
    Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
    Radiology. 2023;308:e230709.
    PubMed     Abstract available

    August 2023
  49. LI X, Zhang Y, Wang X, Zeng H, et al
    Predicting Infectious Complications after Percutaneous Thermal Ablation of Liver Malignancies: A 12-year Single-Center Experience.
    Radiology. 2023;308:e223091.
    PubMed     Abstract available

  50. BEN-ARIE G, Sosna J
    Predicting Infectious Complications after US-guided Ablation of Liver Malignancies: Personalized Patient Care.
    Radiology. 2023;308:e231681.

  51. LI J, Liu G, Xie X, Zhang D, et al
    Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
    Radiology. 2023;308:e223135.
    PubMed     Abstract available

    Combination Systemic Chemotherapy and Ablation Treatment for Potentially Curable Patients with Colorectal Liver Metastases: Ablate Completely and Ablate Early.
    Radiology. 2023;308:e231709.

  53. LI M, Fan Y, You H, Li C, et al
    Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e230255.
    PubMed     Abstract available

  54. WANG X, Liu G, Wu J, Xiao X, et al
    Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
    Radiology. 2023;308:e223201.
    PubMed     Abstract available

  55. CHU LC, Fishman EK
    AI as Virtual Biopsy Tool to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
    Radiology. 2023;308:e231663.

  56. BARTH KH
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation, an Unequal Competition.
    Radiology. 2023;308:e231774.

  57. LI L, Zou X, Zheng W, Li Y, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.
    Radiology. 2023;308:e230150.
    PubMed     Abstract available

  58. BAO Y, Li JX, Zhou P, Tong Y, et al
    Identifying Proliferative Hepatocellular Carcinoma at Pretreatment CT: Implications for Therapeutic Outcomes after Transarterial Chemoembolization.
    Radiology. 2023;308:e230457.
    PubMed     Abstract available

  59. KIM TK
    Contrast-enhanced US Incorporating Kupffer-Phase Findings for the Diagnosis of Hepatocellular Carcinoma.
    Radiology. 2023;308:e231494.

    July 2023
  60. WANG C, Huang Y, Liu C, Liu F, et al
    Erratum for: Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023;308:e239019.

    June 2023
  61. BARR RG, Scoutt LM
    Screening for Hepatocellular Carcinoma:Image Quality Is Everything!
    Radiology. 2023;307:e231089.

  62. PARK MK, Lee DH, Hur BY, Lee HC, et al
    Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Radiology. 2023;307:e222106.
    PubMed     Abstract available

  63. HONG CW, Chernyak V, Choi JY, Lee S, et al
    A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
    Radiology. 2023;307:e222855.
    PubMed     Abstract available

    Reliability of LI-RADS for MRI and CT: Is Excellence Achievable?
    Radiology. 2023;307:e231066.

  65. GALGANO SJ, Smith EN
    LI-RADS Version 2018 for MRI and CT: Interreader Agreement in Real-World Practice.
    Radiology. 2023;307:e231212.

    May 2023
  66. PENG D, Cao J, Guo C, He J, et al
    Influence of Cirrhosis on (68)Ga-FAPI PET/CT in Intrahepatic Tumors.
    Radiology. 2023 May 23:222448. doi: 10.1148/radiol.222448.
    PubMed     Abstract available

  67. NACHIT M, Horsmans Y, Summers RM, Leclercq IA, et al
    AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
    Radiology. 2023 May 16:222008. doi: 10.1148/radiol.222008.
    PubMed     Abstract available

  68. GOINS SM, Adamo RG, Lam E, Costa AF, et al
    Conversion Strategy for LI-RADS Category 5 Observations across Versions 2014, 2017, and 2018.
    Radiology. 2023;307:e222971.

    April 2023
  69. XIA TY, Zhou ZH, Meng XP, Zha JH, et al
    Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model.
    Radiology. 2023 Apr 25:222729. doi: 10.1148/radiol.222729.
    PubMed     Abstract available

    Radiomics to Predict Microvascular Invasion in Hepatocellular Carcinoma: A Promising Biomarker for Tumor Recurrence.
    Radiology. 2023 Apr 25:230657. doi: 10.1148/radiol.230657.

  71. FOWLER KJ, Chernyak V, Ronot M, Vilgrain V, et al
    Hepatocellular Carcinoma: It Is Time to Focus on Prognosis.
    Radiology. 2023 Apr 4:220884. doi: 10.1148/radiol.220884.

  72. RONOT M, Chernyak V, Burgoyne A, Chang J, et al
    Imaging to Predict Prognosis in Hepatocellular Carcinoma: Current and Future Perspectives.
    Radiology. 2023 Apr 4:221429. doi: 10.1148/radiol.221429.
    PubMed     Abstract available

  73. CHERNYAK V, Fowler KJ, Do RKG, Kamaya A, et al
    LI-RADS: Looking Back, Looking Forward.
    Radiology. 2023;307:e222801.
    PubMed     Abstract available

  74. FERRAIOLI G, Barr RG
    Interpreting Liver Stiffness Values in Clinical Practice: Is Histologic Classification Necessary for Clinical Relevance?
    Radiology. 2023;307:e220553.

  75. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2023;307:e239005.

    March 2023
  76. GRANT EG
    Calibrated US for Quantification of Fatty Liver Disease.
    Radiology. 2023;306:e221540.

  77. SUGIMOTO K, Lee DH, Itoi T
    Response to "Limitations of a Multiparametric US Score for NASH Prediction".
    Radiology. 2023;306:e221498.

    February 2023
  78. YEOM A, Chi SA, Song KD
    Added Value of Pelvic CT after Treatment of HCC.
    Radiology. 2023 Feb 21:222314. doi: 10.1148/radiol.222314.
    PubMed     Abstract available

  79. JIANG H, Wei H, Yang T, Qin Y, et al
    VICT2 Trait: Prognostic Alternative to Peritumoral Hepatobiliary Phase Hypointensity in HCC.
    Radiology. 2023 Feb 14:221835. doi: 10.1148/radiol.221835.
    PubMed     Abstract available

    Beyond LI-RADS: Decoding the Prognostic Value of MRI Findings in HCC.
    Radiology. 2023 Feb 14:223309. doi: 10.1148/radiol.223309.

    January 2023
  81. ROLDAN-ALZATE A, Reeder SB
    Image-based Vascular Modeling for Portal Hypertension Diagnosis.
    Radiology. 2023 Jan 31:223163. doi: 10.1148/radiol.223163.

  82. WANG C, Huang Y, Liu C, Liu F, et al
    Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
    Radiology. 2023 Jan 31:221648. doi: 10.1148/radiol.221648.
    PubMed     Abstract available

    Automated Segmentation of CT-guided Ablation Margins in Colorectal Liver Metastases: How We Move Forward to a Standardization of Ablation Zone Assessment.
    Radiology. 2023 Jan 31:223276. doi: 10.1148/radiol.223276.

  84. LIN YM, Paolucci I, O'Connor CS, Anderson BM, et al
    Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
    Radiology. 2023 Jan 31:221373. doi: 10.1148/radiol.221373.
    PubMed     Abstract available

  85. KIM H
    The Feasibility of Abbreviated MRI for Active Surveillance of Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:223113. doi: 10.1148/radiol.223113.

  86. YOKOO T, Masaki N, Parikh ND, Lane BF, et al
    Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
    Radiology. 2023 Jan 24:220917. doi: 10.1148/radiol.220917.
    PubMed     Abstract available

  87. LEE S, Kim YY, Shin J, Son WJ, et al
    Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis.
    Radiology. 2023 Jan 10:220646. doi: 10.1148/radiol.220646.
    PubMed     Abstract available

  88. RONOT M
    Is MRI Better than CT for the LI-RADS?
    Radiology. 2023 Jan 10:222755. doi: 10.1148/radiol.222755.

  89. SIDHU PS, Fang C
    US-based Hepatic Fat Quantification: An Emerging Technique and Game Changer?
    Radiology. 2023 Jan 3:223002. doi: 10.1148/radiol.223002.

  90. JEON SK, Lee JM, Joo I, Yoon JH, et al
    Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
    Radiology. 2023 Jan 3:221510. doi: 10.1148/radiol.221510.
    PubMed     Abstract available

  91. FUJITA S, Sano K, Cruz G, Fukumura Y, et al
    MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study.
    Radiology. 2023;306:150-159.
    PubMed     Abstract available

    December 2022
  92. YOON JH, Kim H
    CT Radiomics in Oncology: Insights into the Tumor Microenvironment of Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:222988. doi: 10.1148/radiol.222988.

  93. FENG Z, Li H, Liu Q, Duan J, et al
    CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
    Radiology. 2022 Dec 13:221291. doi: 10.1148/radiol.221291.
    PubMed     Abstract available

  94. SENDUR HN, Cerit MN
    Reliable Assessment of US Performance for Liver Fat Quantification.
    Radiology. 2022;305:E70.

  95. WU W, Jing X, Xue GQ, Zhu XL, et al
    A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.
    Radiology. 2022;305:721-728.
    PubMed     Abstract available

  96. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022;305:E73.

    November 2022
  97. ZHANG W, Huang C, Yin T, Miao X, et al
    Ultrasensitive US Microvessel Imaging of Hepatic Microcirculation in the Cirrhotic Rat Liver.
    Radiology. 2022 Nov 22:220739. doi: 10.1148/radiol.220739.
    PubMed     Abstract available

    US Microvessel Imaging of Rat Liver Microcirculation: Opportunities and Challenges for Human Imaging.
    Radiology. 2022 Nov 22:222735. doi: 10.1148/radiol.222735.

  99. FETZER DT, Rosado-Mendez IM, Wang M, Robbin ML, et al
    Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization.
    Radiology. 2022;305:265-276.
    PubMed     Abstract available

  100. YOON JH
    A Placebo Effect on MRI Proton Density Fat Fraction in Nonalcoholic Steatohepatitis Trials.
    Radiology. 2022 Nov 1:222295. doi: 10.1148/radiol.222295.

  101. NEDRUD MA, Chaudhry M, Middleton MS, Moylan CA, et al
    MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.
    Radiology. 2022 Nov 1:220743. doi: 10.1148/radiol.220743.
    PubMed     Abstract available

    October 2022
  102. WEIJERS G, Munsterman ID, Thijssen JM, Kuppeveld H, et al
    Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard.
    Radiology. 2022 Oct 18:220104. doi: 10.1148/radiol.220104.
    PubMed     Abstract available

  103. WEAR KA, Han A, Rubin JM, Gao J, et al
    US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Oct 18:220606. doi: 10.1148/radiol.220606.
    PubMed     Abstract available

  104. KITAO A, Matsui O, Zhang Y, Ogi T, et al
    Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
    Radiology. 2022 Oct 11:220531. doi: 10.1148/radiol.220531.
    PubMed     Abstract available

  105. HSIEH SS, Cook DA, Inoue A, Gong H, et al
    Understanding Reader Variability: A 25-Radiologist Study on Liver Metastasis Detection at CT.
    Radiology. 2022 Oct 4:220266. doi: 10.1148/radiol.220266.
    PubMed     Abstract available

  106. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    PubMed     Abstract available

    September 2022
  107. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.

  108. GHELFI J, Decaens T, Macek Jilkova Z
    Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
    Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.

  109. VALENCIA SA, Romero JA
    Limitations of a Multiparametric US Score for NASH Prediction.
    Radiology. 2022;304:E50.

    August 2022
  110. XIE J, Wei X
    Cirrhosis-related Spontaneous Mesocaval Shunt.
    Radiology. 2022 Aug 23:220564. doi: 10.1148/radiol.220564.
    PubMed     Abstract available

  111. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    PubMed     Abstract available

  112. DEIPOLYI AR, Johnson CB, Riedl CC, Kunin H, et al
    Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis.
    Radiology. 2022 Aug 16:220158. doi: 10.1148/radiol.220158.
    PubMed     Abstract available

  113. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    PubMed     Abstract available

  114. LUQUE-CABAL M, Alvarez-Guisasola V, Rizzo-Raza S, Sales-Fernandez C, et al
    Case 304: Porphyria Cutanea Tarda.
    Radiology. 2022;304:488-492.
    PubMed     Abstract available

  115. TORKIAN P, Akhlaghpoor S
    Considerations Regarding Image-guided Treatment of Liver Hemangioma.
    Radiology. 2022;304:E45.

  116. YAN Y
    Three-dimensional MR Elastography in Distinguishing Necroinflammation from Liver Fibrosis.
    Radiology. 2022;304:E43.

  117. BARR RG
    US-targeted Microbubbles to Assess Liver Fibrosis.
    Radiology. 2022;304:483-484.

    July 2022
    Evaluating Hepatic Steatosis with MRI as the Reference Standard: Different Performances of Three US Machines.
    Radiology. 2022 Jul 12:221177. doi: 10.1148/radiol.221177.

  119. CASSINOTTO C, Jacq T, Anselme S, Ursic-Bedoya J, et al
    Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines.
    Radiology. 2022 Jul 12:212846. doi: 10.1148/radiol.212846.
    PubMed     Abstract available

    June 2022
  120. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    PubMed     Abstract available

  121. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.

  122. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.

    May 2022
  123. KHANNA G, Alazraki AL
    Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease.
    Radiology. 2022 May 24:221066. doi: 10.1148/radiol.221066.

  124. ALVES VPV, Dillman JR, Tkach JA, Bennett PS, et al
    Comparison of Quantitative Liver US and MRI in Patients with Liver Disease.
    Radiology. 2022 May 24:212995. doi: 10.1148/radiol.212995.
    PubMed     Abstract available

  125. RAMAN AG, Jones C, Weiss CR
    Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
    Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
    PubMed     Abstract available

  126. MIAO X, Sha T, Zhang W, Zhou H, et al
    Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats.
    Radiology. 2022 May 3:212325. doi: 10.1148/radiol.212325.
    PubMed     Abstract available

    April 2022
  127. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
    Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
    PubMed     Abstract available

  128. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.

  129. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    PubMed     Abstract available

  130. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.

    March 2022
  131. ITO K
    US-derived Fat Fraction Screening of Hepatic Steatosis.
    Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.

  132. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    PubMed     Abstract available

  133. LEE JT
    Sarcopenia at Abdominal CT in Patients with Cirrhosis.
    Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.

  134. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
    Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
    Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
    PubMed     Abstract available

  135. LIU J, Ma J, Yang C, Chen M, et al
    Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
    PubMed     Abstract available

  136. DHONDT E, Lambert B, Hermie L, Huyck L, et al
    (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
    Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
    PubMed     Abstract available

  137. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
    Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
    PubMed     Abstract available

  138. DUAN L, Zhang BH, Zheng XH
    No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.

    February 2022
  139. CHUNG JW
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
    Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.

  140. ZHENG K, Zhu X, Fu S, Cao G, et al
    Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
    PubMed     Abstract available

    January 2022
  141. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
    US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
    PubMed     Abstract available

  142. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
    Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
    Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
    PubMed     Abstract available

  143. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    PubMed     Abstract available

    December 2021
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.

  145. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
    Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
    Radiology. 2021;301:625-634.
    PubMed     Abstract available

    November 2021
  146. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    PubMed     Abstract available

  147. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
    Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
    PubMed     Abstract available

  148. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    PubMed     Abstract available

  149. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    PubMed     Abstract available

    October 2021
  150. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    PubMed     Abstract available

  151. REEDER SB
    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.

  152. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.

    September 2021
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.

  154. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    PubMed     Abstract available

  155. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    PubMed     Abstract available

  156. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    PubMed     Abstract available

    August 2021
  157. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    PubMed     Abstract available

  158. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    PubMed     Abstract available

    July 2021
  159. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    PubMed     Abstract available

  160. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    PubMed     Abstract available

  161. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.

  162. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    PubMed     Abstract available

    June 2021
  163. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    PubMed     Abstract available

  164. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.

    May 2021
  165. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    PubMed     Abstract available

  166. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.

  167. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    PubMed     Abstract available

  168. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    PubMed     Abstract available

    April 2021
  169. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    PubMed     Abstract available

  170. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    PubMed     Abstract available

  171. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    PubMed     Abstract available

    March 2021
  172. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    PubMed     Abstract available

  173. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.

    February 2021
  174. REEDER SB
    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.

    January 2021
  175. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    PubMed     Abstract available

  176. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.

  177. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    PubMed     Abstract available

    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.

  179. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    PubMed     Abstract available

  180. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    PubMed     Abstract available

    November 2020
  181. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.

    October 2020
  182. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.